All news

Moderna surges 10% as $0.38 EPS crushes forecast loss and revenue tops

Investing.com via Yahoo Finance · · AI-summarised by FinFlash

Moderna shares climbed 10% before the bell after adjusted earnings of $0.38 a share beat an expected loss of

So What?

The size of the beat doubled the stock's earlier premarket gain and lifts sentiment across vaccine makers. Durability of international contract revenue is what to watch next.

Read original source

MRNA company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.